Synonyms: AL-001 | AL001
Compound class:
Antibody
Comment: Latozinemab (AL001) is an anti-sortilin 1 (SORT1) monoclonal antibody. It is proposed to elevate progranulin levels by inhibiting the SORT1-mediated degradation pathway for progranulin (PGRN). This mechanism is being investigated as a disease‐modifying therapy for patients with frontotemporal dementia caused by loss-of-function mutations in GRN.
|
Classification ![]() |
|
Compound class | Antibody |
International Nonproprietary Names ![]() |
|
INN number | INN |
11584 | latozinemab |
Synonyms ![]() |
AL-001 | AL001 |
Database Links ![]() |
|
Specialist databases | |
IMGT/mAb-DB | 1130 |
Other databases | |
GtoPdb PubChem SID | 507750319 |
Search PubMed clinical trials | latozinemab |
Search PubMed titles | latozinemab |
Search PubMed titles/abstracts | latozinemab |